Skip to Content
Merck

639869

4-Phenylpiperidine

97%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C11H15N
CAS Number:
Molecular Weight:
161.24
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
212-243-1
Beilstein/REAXYS Number:
124508
MDL number:
Assay:
97%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

97%

mp

61-65 °C (lit.)

functional group

phenyl

SMILES string

C1CC(CCN1)c2ccccc2

InChI

1S/C11H15N/c1-2-4-10(5-3-1)11-6-8-12-9-7-11/h1-5,11-12H,6-9H2

InChI key

UTBULQCHEUWJNV-UHFFFAOYSA-N



pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

ppe

dust mask type N95 (US), Eyeshields, Gloves



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



A G Ishkov et al.
Voprosy meditsinskoi khimii, 38(2), 25-28 (1992-03-01)
A rate of utilization of 4-phenyl piperidine and its 12 derivatives by brain monoamine oxidase (MAO) was studied as compared with typical neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The enzyme was isolated from P2 synaptosomal fraction of brain corpus striatum of Sprague-Dawley rats.
Clandestine drug synthesis.
W H Soine
Medicinal research reviews, 6(1), 41-74 (1986-01-01)
Diane K Luci et al.
Bioorganic & medicinal chemistry letters, 17(23), 6489-6492 (2007-10-16)
Various 4-phenylpiperidine-benzoxazin-3-ones were synthesized and biologically evaluated as urotensin-II (U-II) receptor antagonists. Compound 12i was identified from in vitro evaluation as a low nanomolar antagonist against both rat and human U-II receptors. This compound showed in vivo efficacy in reversing